Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
Conclusion: Major limitations of the reviewed studies were short trial duration, small sample sizes, and the lack of control groups. Defining the potential role of DUL in the treatment of psychiatric disorders other than major depressive disorder and generalized anxiety disorder needs further randomized, placebo-controlled studies.
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
More News: Anxiety | Borderline Personality Disorder | Brain | Chronic Pain | Cymbalta | Databases & Libraries | Depression | Diabetes | Endocrinology | Fibromyalgia | Generalized Anxiety Disorder (GAD) | Neurology | Pain | Panic Disorder | PET Scan | Psychiatry | Schizophrenia | Study